Microvascular Genesis of Diseases: From Hypothesis to Theory

Ruslan A Nasyrov1, Veronika A Galichina1, Anna O Drobintseva2

  • 1Department of Pathological Anatomy, St. Petersburg State Pediatric Medical University, Ministry of Health of Russia, St. Petersburg 194100, Russia.

Life (Basel, Switzerland)
|February 27, 2026
PubMed

Insights

This study revises disease pathogenesis, highlighting microvasculature damage as the primary event. This microvascular injury triggers parenchymal cell changes, offering new therapeutic targets for infectious and non-infectious diseases.

Area of Science:

  • Pathology
  • Microvascular Medicine
  • Cellular Biology

Background:

  • Traditional disease pathogenesis focuses on direct pathogen damage to parenchymal cells.
  • Existing morphological studies offer limited insight into microvasculature's role in disease.
  • A paradigm shift is needed to incorporate microvascular dynamics into disease explanations.

Purpose of the Study:

  • To propose a revised concept of disease pathogenesis centered on the microvasculature.
  • To investigate the microvasculature's role as the primary target in both infectious and non-infectious diseases.
  • To elucidate the cellular and molecular interactions driving disease development.

Main Methods:

  • Comprehensive literature search of international databases (current as of December 2025).
  • Analysis of authors' own research data from 1989 to present.
  • Inclusion of data from studies on non-infectious diseases.

Main Results:

  • Microvessels are identified as the initial site of damage in pathological processes.
  • Microvascular injury triggers a cascade of changes in parenchymal cells, driving disease.
  • Novel data support the microvasculature's central role in both infectious and non-infectious diseases.

Conclusions:

  • The microvasculature is the primary target in early-stage disease, not parenchymal cells.
  • This revised concept offers a new framework for understanding disease mechanisms.
  • The findings open avenues for innovative therapeutic strategies targeting microvascular dysfunction.

Related Concept Videos

Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
7.3K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.9K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.8K
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.2K